Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Tryozi

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Tryozi head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 66 · Grade C

Tryozi

Visit Tryozi Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 78 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Tryozi a bad call — it's best for people comparing a monthly compounded program who will check the price promise and cancellation cutoff before enrollment. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
58
Supply Reliability
95
81
Transparency
90
88
Access Breadth
93
90
Clinical Oversight
92
74
Track Record
88
80
CoreAge RxBrief Score 94 · 78Tryozi

Price, coverage & the tracker

CoreAge RxTryozi
Brief Score94/100 (A)78/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$79/mo advertised offer

Confirm lifetime-price conditions, taxes and automatic renewal.

Full price details

$79/mo advertised compounded injection offer; automatic renewal; confirm lifetime-price conditions and applicable taxes

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$129/mo advertised offer

Confirm lifetime-price conditions, taxes and automatic renewal.

Full price details

$129/mo advertised compounded injection offer; automatic renewal; confirm lifetime-price conditions and applicable taxes

CoverageUS only; restrictions by state, confirmed at intakeAll 50 states and D.C. advertised; some services unavailable in some states, subject to clinical eligibility
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Tryozi: The advertised monthly offers are $79 for semaglutide and $129 for tirzepatide. Confirm price-lock conditions, taxes and renewal terms rather than relying on the repeating countdown.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.